Small pump can boost the heart to buy time
Children born with a single functional ventricle are palliated with a Fontan procedure, often by the age of 3. In the absence of one ventricle, this procedure reroutes venous blood to the pulmonary arteries for reoxygenation in the lungs.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A large proportion of these children do well for years before needing a heart transplant. However, 20 to 30 percent may develop chronic venous hypertension leading to liver damage, making them ineligible for transplantation. In these patients, a ventricular assist device (VAD) can improve the Fontan circuit by boosting the single ventricle’s pumping power. This can improve the child’s health and buy valuable time.
“There is a common misunderstanding that when a Fontan fails, we can’t do anything for the patient. It’s important to know that this is not true. We have successfully bridged a lot of these patients to transplant with a VAD,” says Hani Najm, MD, Chair of Pediatric and Congenital Heart Surgery at Cleveland Clinic.
Cleveland Clinic Children’s has one of the most active pediatric VAD programs in the country. Last year, Dr. Najm and colleagues implanted eight VADs in children and adults with congenital heart defects or cardiomyopathies. Some patients were on the transplant list; others were not.
“We are one of few centers that will implant a VAD in someone who is not yet a transplant candidate. We have found they often improve when their heart is assisted. This makes them a better transplant candidate later on,” Cleveland Clinic Children’s Pediatric Cardiology Chair Elizabeth Saarel, MD, explains.
In addition to its small size that allows the VAD to be implanted in children weighing as little as 20 kg, the device is portable. As a result — and building on Cleveland Clinic’s vast experience with VADs in adults — the pediatric VAD program has added an outpatient component.
Advertisement
“We are one of only three centers in the country with this program,” says Dr. Saarel.
As soon as possible after surgery, the child is sent to Cleveland Clinic Children’s Hospital for Rehabilitation to begin the recovery process. The VAD’s cable, battery and power pack enable physical and occupational therapy to be conducted without hindrance. As the child grows stronger, the parents develop confidence in caring for the VAD and can look forward to returning home as a family.
VADs are only one component in an array of techniques and technologies for children whose Fontan fails. Options include repairing the defective valve or baffle or eliminating an arch obstruction to improve blood flow.
When a high transforming gradient results despite these efforts, a VAD may be considered.
Referring physicians are encouraged to contact Drs. Najm or Saarel for a consult as soon as a patient with a single ventricle begins to fail.
“We like to see patients sooner rather than later. Often we can do surgery — albeit complex — to prevent the need for a VAD or heart transplant. It’s our goal to ward off the worst outcome,” says Dr. Najm.
Advertisement
Advertisement
Site visits offer firsthand lessons in clinical and operational excellence in cardiovascular care
‘Concise clinical guidance’ from ACC distills key advances in imaging and pharmacotherapy
Recent Cleveland Clinic experience reveals hundreds of cases with anatomic constraints to FEVAR
Join us in New York City Dec. 5-6
Study supports addressing mitral regurgitation before mild tricuspid regurgitation progresses
Least-invasive open-heart AVR option to date yielded rapid recovery in all cases
New analyses confirm preservation of ablation outcomes, broaden data on bleeding benefits
HALT has unique clinical implications for adults with congenital heart disease